Close Menu
Home
Call
Email
Search
Menu
Schedule Your Free Confidential Consultation
800-654-8281
Get Started today
Home
Who We Are
Reuben A. Guttman, Esq.
Philip Freidin, Esq.
Richard Celler, Esq.
Traci I. Buschner, Esq.
Jonathan E. Freidin, Esq.
Elizabeth H. Shofner, Esq
Justin S. Brooks, Esq.
Whitney M. Untiedt, Esq.
Our Confidential Process
Why Whistleblowers Choose Us
Types of Fraud
Government Program Fraud
Defense Fraud
Research Fraud
Equipment Fraud
COVID-19 Fraud
Medicare Fraud
Medicare Part D Fraud
Billing for Care not provided
Upcoding
Prescribing unnecessary medications
Off-Label Promotion
Providing or accepting kickbacks for referrals
Waiving Co-Pay
Nursing Home Quality of Care Violations
Pharmaceutical Fraud
Compounding Pharmacy Fraud
Education Fraud
Federal Student Aid Fraud
False Enrollment fraud
Student Recruiter Incentive Fraud
False Scholarship and Financial Aid Assistance
Admission Fraud
Grant and Research Fraud
Accreditation Fraud
Charter School Fraud
Other Education Fraud Abuses
Healthcare Billing Fraud
Hospital Fraud
Hospice Fraud
Telemedicine Fraud
IRS Whistleblowers
FAQ
Laws that Protect Whistleblowers
Protection from Retaliation – OSHA
Protection from Retaliation – FLSA
Protection from Retaliation – NLRA
What is Upcoding and Unbundling?
Resources
How to Report Medicare Fraud
Qui Tam Claims
Fraud Alert: For Profit Colleges
What is the False Claims Act
False Claims Act Penalties
The Florida Whistleblower Act
Florida False Claims Act
Referrals
Blog
Contact Us
+
Search
Florida Whistleblower Lawyers
>
Thank You
Thank You
Your form has been submitted.
Share This Page:
Practice Areas
Government Program Fraud
COVID-19 Fraud
Medicare Fraud
Florida Nursing Home Quality of Care Violations
Pharmaceutical Fraud
Compounding Pharmacy Fraud
Education Fraud
Healthcare Billing Fraud
Hospital Fraud
Hospice Fraud
Telemedicine Fraud
IRS Whistleblowers
We Have Successfully Recovered Over $5 Billion For Our Clients
$1.6 billion
ABBOTT LABS
U.S. ex rel. McCoyd v. Abbott Laboratories
Western District of Virginia
$1.04 billion
GlaxoSmithKline
U.S. ex rel. Graydon v. GlaxoSmithKline
District of Massachusetts
$2.3 billion
Pfizer
U.S. ex rel. Doghramji, et al. v. Community Health Systems Inc., et al.
Eastern District of Pennsylvania
$97 million
Community Health Systems
U.S. ex rel. Doghramji, et al. v. Community Health Systems Inc., et al.
Middle District of Tennessee
